We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Chronic Inflammation Linked to Risk for Alzheimer's Disease

By LabMedica International staff writers
Posted on 30 Oct 2018
Print article
Image: The Dade Behring BN100 nephelometer (Photo courtesy of Siemens Healthineers).
Image: The Dade Behring BN100 nephelometer (Photo courtesy of Siemens Healthineers).
While it has been widely shown that possessing the apolipoprotein E4 (ApoE4) gene is the major genetic risk factor of Alzheimer's disease (AD), not all ApoE4 carriers develop AD. It is likely that a complex interaction of genetic vulnerabilities with environmental risk factors lead to AD and identifying such factors could be beneficial for the prevention of AD.

C-reactive protein (CRP) is an immune system response to toxins or injuries in systemic inflammation, while CRP levels increase with age. Although multiple AD-related genes are associated with the level of CRP, the association between blood CRP levels and risk of AD are not conclusive as previous studies have presented both low and high levels of CRP in patients with AD.

Scientists at Boston University School of Medicine (Boston, MA, USA) in a cohort study, evaluated data from 2656 members of the Framingham Heart Study offspring including longitudinal measures of serum C-reactive protein (CRP), diagnoses of incident dementia including AD, and brain volume. Chronic low-grade inflammation was defined as having CRP at a high cutoff level at a minimum of two time points.

CRP concentrations at examinations two and six were performed in the Framingham Heart Study laboratory using a previously described enzymatic immunoassay. The CRP measurement at examination seven was conducted by a Dade Behring BN100 nephelometer. Data on a subset of 1,785 individuals, who also underwent brain magnetic resonance imaging (MRI) after the seventh examination were used for secondary analyses to examine the association between CRP, ApoE, and AD-related changes in brain structure.

The scientists found that during the 17 years of follow-up, 194 individuals (7.3%) developed dementia, 152 (78.4%) of who had AD. ApoE4 coupled with chronic low-grade inflammation, defined as a CRP level of 8 mg/L or higher, was associated with an increased risk of AD, especially in the absence of cardiovascular diseases (hazard ratio = 6.63), as well as an increased risk of earlier disease onset compared with ApoE4 carriers without chronic inflammation. A subset of 1,761 individuals (66.3%) underwent brain magnetic resonance imaging, and the interaction between ApoE4 and chronic low-grade inflammation was associated with brain atrophy in the temporal lobe and hippocampus.

Wendy Qiao Qiu, MD, PhD, an associate professor of psychiatry and senior author of the study, said, “Finding out what mediating factors for ApoE4 increase AD risk is important for developing intervention and prevention of the disease. Since many elders have chronic low-grade inflammation after suffering from common diseases like cardiovascular diseases, diabetes, pneumonia and urinary tract infection, or after having surgeries, rigorously treating chronic systemic inflammation in ApoE4 carriers could be effective for prevention of Alzheimer's dementia.” The study was published on October 19, 2018, in the journal JAMA Network Open.

Related Links:
Boston University School of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.